EUVC ’s Post

It's time to get to know a little bit more about the winners of the European VC Awards. 🏆 Today, we introduce you to Amino Collective. The winner of Newcomer of The Year. 🥇 Who is Amino Collective? Amino Collective is an institutional venture capital firm investing in health and bio companies at the seed stage. Who is moving the needle? Manuel Grossmann, solo GP of the fund. A few cool things about them? - secured €40M in record time - attracted Tier 1 Limited Partners - added €150M in follow-on funding - joined by investors like A16z, Index Ventures, and Accel. The Newcomer of the Year award celebrates rising managers who bring fresh perspectives to European ventures. This category has been supported by Floww, a solution that simplifies venture capital fund management, with FlowwFunds, a full funds management solution. ps. Make sure to turn on the sound if you watch the video for an entertaining soundtrack! 🔊 #VentureCapital #StartupFunding #Fundraising #EuropeanVCAwards #Europe

🌟 Recognizing Excellence in Venture Capital! 🌟 We're thrilled to invite nominations for the VC Firm of the Year award at the European Lifestars Awards! This is your chance to honor a venture capital firm that has shown outstanding investment strategies, significant value creation, and exemplary performance in the life sciences sector! This prestigious award acknowledges firms that have excelled in: 💡 Deal-making strategies 📈 Volume and value of investments made between 1 September 2023 and 1 August 2024 🚀 Number of lead investments made 🏆 Number and quality of successful exits 💰 Number and value of new funds raised 📊 Fund performance and returns to LPs To qualify, firms must: - Have more than 20% of portfolio holdings in healthcare and/or life sciences companies - Have headquarters in Europe Nominate a deserving firm today and help us honor their dedication to innovation and growth in the European life sciences landscape! 👉 Submit your nomination here: https://lnkd.in/ezjTkn6f ✨ Get inspired by last year’s winner: Watch the video of Forbion’s success story, then nominate this year’s standout performer! #LifestarsAwards #VentureCapital #Innovation #LifeSciences

🆕 𝟏𝟖𝟎 𝐕𝐂-𝐛𝐚𝐜𝐤𝐞𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐟𝐫𝐨𝐦 𝐂𝐞𝐧𝐭𝐫𝐚𝐥 𝐚𝐧𝐝 𝐄𝐚𝐬𝐭𝐞𝐫𝐧 𝐄𝐮𝐫𝐨𝐩𝐞 🚀Kris Przybylak, Inovo.vc, has delved into the healthcare ecosystem in CEE, which seems pretty strong, especially in Poland More than 180 startups have raised VC/angel money since 2020. Almost half of them originate in Poland, where health amounts to 15% of all transactions. The study includes insights from: Johannes Blaschke, Investor Calm/Storm Ventures Paul Epple, Investor YZR Capital Radosław Kuchar, Investment Manager PFR Ventures Link in the comments: #digitalhealth

Biotech venture capitalists are pacing for another record-low year of fundraising. But is a recovery on the horizon? Some VCs have pushed through the recent market downturn and managed to raise funds. Life science VCs had raised just 53 funds in 2023 — the lowest figure in nearly a decade, according to PitchBook. So far, firms have raised 15 funds in 2024, putting them on pace for another low fundraising year. Experts don’t think this boom-and-bust cycle will decimate biotech VCs the same way the 2000s downturn did however. Download STAT's new report for a detailed ranking of biotech venture capital firms based on their returns: https://trib.al/QVltSw5 #STATReports

🚀 Exciting News in Life Sciences Venture Capital! Seroba., the powerhouse Irish life sciences venture capital firm, has successfully closed its latest fund at an impressive €123 million! 💸 This substantial investment is set to fuel innovation in companies addressing critical medical needs, with up to 12 groundbreaking investments planned under Fund IV. 🌍 The fund's strategic focus spans Western Europe and selectively ventures into North America. Already, five visionary companies, including Irish gems Perfuze and Deciphex, have secured investment, propelling them towards transformative advancements in medtech. 🔍 Seroba's track record speaks volumes: 32 investments in life sciences, unleashing 20 revolutionary medical devices and eight therapeutic breakthroughs. Alan O'Connell, Partner at Seroba, emphasises the allure of life sciences for investors, highlighting the perfect timing amidst rapid innovation. 👥 With an expanded team across Dublin, Paris, and Milan, Seroba is primed to navigate a rich pipeline of investment opportunities. Noteworthy is the inclusion of new investors like CDP Venture Capital SGR, a US corporate, and several family offices, joining forces with established partners. 🌱 As we celebrate Seroba's success, let's reflect on the burgeoning interest in life sciences. The field's value has skyrocketed, driven by our collective push towards precision medicine and the integration of AI in healthcare. Seroba's strategic vision aligns seamlessly with this evolution, marking a pivotal moment in advancing patient-centric solutions. 🧠 The convergence of life sciences with AI promises unparalleled insights and personalized treatments. It's a testament to the industry's commitment to enhancing patient outcomes and reshaping the future of healthcare. 🧭 Seroba's journey resonates with the narrative of pioneers shaping the next frontier in healthcare and championing progress in life sciences and steering us toward a future where innovation knows no bounds! #LifeSciences #VentureCapital #Innovation #Investment #HealthcareRevolution #PrecisionMedicine #AIinHealthcare https://lnkd.in/egBkdRzT

Exciting News! Join us at the Litestream Ventures Annual Impact Investment Gathering, set amidst the prestigious World Economic Forum in Davos. An exclusive assembly of 70-100 influential investors, including General Partners, Limited Partners, family offices, angel investors, and high-net-worth individuals, awaits. We're thrilled to showcase 10 visionary founders with groundbreaking solutions, pitching before esteemed impact funds like Astanor Ventures, Sway Ventures European Circular Bioeconomy Fund (ECBF) , Una Terra Venture Capital Fund, KOMPAS VC, Clean Growth Fund, Chi Impact Capital, kopa ventures (formerly Wi Venture), Icos Capital, Litestream Ventures Aligned with the 17 UN SDGs, Litestream is dedicated to spotlighting founders combating climate change and aspiring to 'Unicorn' status. This initiative offers them a unique chance to secure investments from a distinguished panel and the crowd. Sponsored By: Home Grown Club, FieldHouse Associates, The Neurodiversity Edge Save your spot now! Participation is by invitation only. Rsvp: Rsvp@lite-stream.com Questions or need more information? Feel free to contact us directly. We look forward to welcoming you to this prestigious event!  #LitestreamVentures #Litestream #ImpactInvestment #WEF2024 #SDGs #InvestInChange #Astanor, #VitaNovaFund, #SwayVentures #KopaVentures #EuropeanCircularBioeconomyFund, #UnaTerraVentures, #KompasVC, #CleanGrowthFund, #IcosCapital, #EuropeanCircularBioeconomyFund #ChiImpactCapital #KopaVC #WorldEconomicForum 

In the years after the 2000 “dot com” or genomics bubble bursting, eight of the top 10 life sciences investors ultimately went out of business, according to a review by Atlas Venture. (The survivors? MPM Capital and Versant Ventures). What can we expect from this biotech downturn? Three years in, venture capitalists are having a hard time raising new funds. They don't think we'll see a flood of firms going under, but they debate whether the worst is finally over. Do you think all of the biotech VCs will weather the storm? #biotech #biopharma #venturecapital #VC #fundraising #investing #investingstrategies #startupfunding STAT

While large VC firms are raising billion-dollar funds, primarily targeting clinical-stage companies with proven leadership and data. Smaller VC firms are focusing on early-stage companies with experimental science, seeing them as potential future pillars of the sector. This shift has created a more conservative investment landscape, with companies facing higher burdens of proof and needing to be more judicious with resources, especially in the early stages of development. This is a great article. https://lnkd.in/gd_23YxD

The Texas Medical Center (TMC) is a collector of colossal adjectives and accolades. You probably already know it as the largest medical center in the world, also home to the renowned Texas Children's Hospital and MD Anderson Cancer Center. TMC also hosts Baylor College of Medicine, Houston Methodist Hospital, St. Luke's Health, Memorial Hermann Health System, and more. With an impressive 120,000 employees, 10 million patients a year, and more than 180,000 annual surgeries, it’s no surprise that incredible #medical breakthroughs happen at TMC’s academic and research institutions, not to mention its 21 different hospitals. That’s why the impact of its TMC Venture Fund runs the gamut! #VentureCapital is quite a rarity in Houston, in fact. There are only about dozen active venture capital funds based in this city with a metro area of 7.2 million people. While there’s a ton of wealth in Houston, it’s mostly in real estate, wealth management, private equity, energy, etc., not so much in venture capital funds for #medtech #startups. That’s why, in 2017, the TMC Corporation launched the TMC Venture Fund with a humble $25 million—with the TMC Foundation as the sole investor—and the dream of filling a much-needed gap in the Houston venture capital ecosystem. Since its inception, TMC Venture Fund has partnered with 24 startups, with a focus on #digitalhealth and #medicaldevice companies. In 2022, it doubled its fund to $50 million! Something that sets the TMC Venture Fund apart is that all the money that’s made goes right back into the next round of companies. By contrast, in most venture funds, partners pocket the profits, then raise more money instead.

Turkey's life science sector is growing, with 1,440 companies and a focus on Longevity Medicine. Supported by 45 investors and 40 tech-focused investors. Istanbul is key for R&D and startups, aiming to improve healthcare nationally and worldwide. Some of the companies driving forward innovation in this dynamic industrial ecosystem include Collective Spark, D4 Ventures, Diffusion Capital Partners, driventure, EBRD, Eksim Ventures, Esas Private Equity, Esas Ventures, F Ventures LLP, Founder One, Galata Business Angels Official, Geometry Venture Development | Angel Investment Fund, Hackquarters by Tenity, idacapital, iNVENTRAM!, iUGO Technology, Keiretsu Forum Türkiye - Melek Yatırımcı Ağı, LEAP Investment. More info: https://lnkd.in/eb8yj5W8 Regional stakeholders interested in having their own ecosystem mapping platform developed can learn more here: https://lnkd.in/eMSuWyCM #LifeSciences #Innovation #Turkey #HealthTech #Investment #FutureofHealthcare